Expensify, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
EXFY$1.85-9.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(unaudited, in thousands, except share and per share data)
| As of March 31, | As of December 31, | |
|---|---|---|
| 2026 | 2025 | |
| Assets | ||
| Cash and cash equivalents | $66,528 | $63,080 |
| Accounts receivable, net | 12,115 | 12,617 |
| Settlement assets, net | 53,581 | 45,378 |
| Prepaid expenses | 4,792 | 5,588 |
| Other current assets | 21,205 | 26,344 |
| Total current assets | 158,221 | 153,007 |
| Capitalized software, net | 13,269 | 13,596 |
| Property and equipment, net | 12,861 | 13,016 |
| Lease right-of-use assets | 4,559 | 4,730 |
| Deferred tax assets, net | 486 | 494 |
| Other assets | 1,201 | 1,146 |
| Total assets | $190,597 | $185,989 |
| Liabilities and stockholders' equity | ||
| Accounts payable | $938 | $289 |
| Accrued expenses and other liabilities | 7,668 | 17,893 |
| Lease liabilities, current | 648 | 678 |
| Settlement liabilities | 36,083 | 27,545 |
| Total current liabilities | 45,337 | 46,405 |
| Lease liabilities, non-current | 4,910 | 5,061 |
| Other liabilities | 1,822 | 1,778 |
| Total liabilities | 52,069 | 53,244 |
| Commitments and contingencies (Note 4) | ||
| Stockholders' equity: | ||
| Preferred stock, par value $0.0001; 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, par value $0.0001;Class A common stock; 1,000,000,000 shares authorized; 84,272,879 and 80,767,385 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectivelyLT10 common stock; 21,871,197 shares authorized; 4,209,827 shares issued and outstanding as of March 31, 2026 and December 31, 2025,LT50 common stock; 24,893,067 and 24,967,114 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 7,950,037 and 8,083,690 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 10 | 9 |
| Additional paid-in capital | 313,072 | 304,953 |
| Accumulated deficit | (174,554) | (172,217) |
| Total stockholders' equity | 138,528 | 132,745 |
| Total liabilities and stockholders' equity | $190,597 | $185,989 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.